Atrin Pharmaceuticals

Doylestown, United States

Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.

Jul 2022

Series A

Biotechnology Content Discovery Medical Pharmaceutical Therapeutics

Top Investors

Ben Franklin Technology Partners of Southeastern PennsylvaniaKeiretsu CapitalNational Cancer InstituteKeiretsu ForumRobin Hood Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Atrin Pharmaceuticals

Who are Atrin Pharmaceuticals's investors?

Atrin Pharmaceuticals's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, Keiretsu Capital, National Cancer Institute, Keiretsu Forum, Robin Hood Ventures.

Where is Atrin Pharmaceuticals headquartered?

Atrin Pharmaceuticals is headquartered in Doylestown, United States.

What does Atrin Pharmaceuticals do?

Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.

What stage is Atrin Pharmaceuticals at?

Atrin Pharmaceuticals is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 2, 2022.

MLA

"Atrin Pharmaceuticals — Funding & Investors." VCBacked, July 2, 2022, https://www.vcbacked.co/company/atrin-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2022). Atrin Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/atrin-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Atrin Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/atrin-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 2, 2022.